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1998; Ahmed and Gray, 1996; Zinkernagel, 2002). We
think it best, however, to view memory cells not simply
as a cluster of individuals but, instead, as part of an
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55 Lake Avenue North interactive network, which is continually evolving as im-
mune responses composed of some cells alter the fre-Worcester, Massachusetts 01655
quencies, distributions, and activities of others. This net-
work is composed of a diverse repertoire of naive and
memory T cells, which compete with each other forSummary
niches in an ever-changing microcosm. With each virus
infection, the adaptive immune response generates aVirus-specific memory T cell populations demonstrate
plasticity in antigenic and functional phenotype, in rec- diverse repertoire of antigen-specific memory T cells to
a variety of immunodominant epitopes. These T cellsognition of antigen, and in their ability to accommo-
date new memory T cell populations. The adaptability need to be accommodated in many different local envi-
ronments throughout the tissues of the host. Duringof complex antigen-specific T cell repertoires allows
the host to respond to a diverse array of pathogens subsequent infections, the resident memory T cells must
once again compete with the new T cells in the finiteand accommodate memory pools to many pathogens
in a finite immune system. This is in part accounted space of the immune system. These ever-changing net-
works of T cell populations provide the immune systemfor by crossreactive memory T cells, which can be
employed in immune responses and mediate protec- with a resilient plasticity to combat infections.
tive immunity or life-threatening immunopathology.
Plasticity in Functional Phenotypes
Memory T cells display extensive diversity in terms of
Introduction antigenic phenotype, effector function, and anatomical
distribution. Although memory CD8 T cells are consis-
On encountering viral antigens under conditions of ap- tently CD44hi, they are heterogeneous in expression of
propriate costimulation, T cells proliferate and differenti- other surface molecules, including lymph node homing
ate into IFN-producing cytotoxic CD8 T lymphocytes receptors (CD62L, CCR7) (Razvi et al., 1995b; Sallusto
(CTL) and cytokine-producing Th1 (IFN, TNF) or Th2 et al., 1999; Tripp et al., 1995) and molecules associated
(IL-4, IL-5) effector CD4 T cells (Kaech and Ahmed, 2001; with costimulation (CD27, CD28) (Appay et al., 2002;
van Stipdonk et al., 2001; Mercado et al., 2000; Swain, Tomiyama et al., 2002) or activation state (CD45RA and
1999; Dutton et al., 1998). This is a programmed event CD45RO) (Appay et al., 2002; Champagne et al., 2001).
that can be initiated after only brief contact with the Viral antigen-specific CD8 T cells migrate to and reside
antigen-presenting cell (APC). Studies using limiting di- at high frequencies throughout the organs of the host,
lution assays and transfers of CFSE-labeled T cells indi- including lung, kidney, gut, fat pads, and liver (Masopust
cate that CD8 T cells undergo as many as three divisions et al., 2001; Chen et al., 2001; Hogan et al., 2001). In the
a day and divide at least 8 and as many as 15 times absence of antigen, “resting” memory T cells are not
before reaching their peak (Selin et al., 1996; Kaech and quiescent. A portion of the memory CD8 T population
Ahmed, 2001). Viral titers are greatly reduced during this undergoes a continuous but low-level homeostatic pro-
T cell expansion phase, after which the T cells decline liferation that must be offset by apoptosis, as their fre-
in number. This silencing of the T cell response is a quencies remain stable (Sprent and Tough, 1996; Zim-
consequence of T cell apoptosis in spleen and lymph mermann et al., 1996). Blast-size memory CD8 T cells
nodes and of the dissemination of T cells into the periph- in the spleens of lymphocytic choriomeningitis (LCMV)-
eral tissue (Razvi et al., 1995a; Masopust et al., 2001; immune mice are cytolytically active when exposed to
Marshall et al., 2001). Some of these T cells resist the sensitive targets, indicating that some memory cells ex-
apoptotic events and enter a memory pool, where they ist in an effector state (Selin and Welsh, 1997). These
provide enhanced protection of the host on reexposure cytolytically active “effector memory” cells are also
to a pathogen and act to prevent low-grade persisting present at relatively high levels in the peripheral tissues
viruses from reemerging. of mice immune to vesicular stomatitis virus (Masopust
Protective immunity to viruses is thought to be best et al., 2001). Examination of memory cells by their physi-
mediated by B cell-secreted neutralizing antibody, but cal or functional phenotype and anatomical location led
vaccines that induce T cell in addition to B cell memory some investigators to describe memory T cells in terms
responses may provide better protective immunity of two major subsets: central memory cells, which ex-
(Amara et al., 2001; Kaech et al., 2002). Memory T cells press CCR7 (or CD62L) and localize in secondary lymphoid
need to be antigen specific, easy to reactivate, and pres- tissue, and effector memory cells, which lack CCR7 (or
ent at a high frequency for a substantial period of time CD62L) and remain in peripheral organs (Sallusto et al.,
to be fully effective in this role. Previous reviews have 1999; Champagne et al., 2001).
described these aspects of T cell memory (Dutton et al., There is controversy over whether this memory T cell
heterogeneity is a function of different stages in a linear
differentiation pathway or whether it reflects plasticity*Correspondence: raymond.welsh@umassmed.edu
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in T cell antigenic and functional phenotype as a conse- selective proliferation or apoptosis of T cells within
those subtypes.quence of exposure to different types of antigenic stimuli
within different microenvironments (Appay et al., 2002; Memory CD8 T cells responding to different viruses
may display a different phenotypic profile. For instance,Catalina et al., 2002; Baron et al., 2003). Three models
have recently been proposed for lineage differentiation. the predominant memory CD8 T cell populations are
CD45RACD27CD28 against EBV and HCV, CD45RAThe first model is based on expression of L-selectin
(CD62L) and CCR7, which are receptors involved in CD28CD27 against HIV, and CD45RACD27CD28
against CMV (Appay et al., 2002; Tomiyama et al., 2002;homing to lymphoid tissue. These two receptors, along
with the presence or absence of CD45RA, define three Champagne et al., 2001). The phenotype of T cells di-
rected against different epitopes encoded by the samesubsets of memory cells: central memory cells, effector
memory cells, and terminally differentiated effector cells virus can also be different within the same individual
(Catalina et al., 2002; Hislop et al., 2002). For example,(Sallusto et al., 1999). Examinations of HIV- and human
cytomegalovirus (HCMV)-specific CD8 T cells led inves- T cells responding to the HLA-A2-restricted BMLF-1
lytic epitope of EBV, which is expressed on infected Btigators to propose a linear differentiation scheme
whereby naive CD4 or CD8 T cells (CD45RACD62L cells, are CCR7 and equally mixed with CD45RA or
CD45RA cells. In contrast, responses to the EBV latentCCR7) on encountering antigen mature into central
memory cells (CD45CD62LCCR7), effector memory epitopes, which are predominantly expressed in the ton-
sils, are associated with CCR7 CD45RA cells.cells (CD45RACD62LCCR7), and finally, terminally
differentiated effector cells (CD45RACD62LCCR7) The human infections listed above are all persistent
to some degree, and T cells present during persistent(Champagne et al., 2001). The second model for human
T cell differentiation is based on downregulation of the infections are particularly heterogeneous at the func-
tional level. Examples of this heterogeneity include cyto-costimulatory molecules CD27 and CD28, along with
CD45RA in HCMV- and Epstein Barr virus (EBV)-specific kine-producing weakly cytotoxic cells low in perforin, as
shown with HIV (Appay et al., 2000); cytokine-producingT cell responses. In this pathway, naive cells (CD45RA
CD27CD28) mature into early-differentiated cells weakly cytotoxic cells high in perforin, as shown in mu-
rine polymavirus infections (Moser et al., 2001); and(CD45RACD28CD27), intermediate cells (CD45RA
CD28CD27), and finally, fully differentiated cells weakly cytotoxic cells that do not produce cytokines,
as shown in SIV infection in monkeys (Xiong et al., 2001).(CD45RACD28CD27) (Tomiyama et al., 2002; Wills
et al., 2002; Hamaan et al., 1997). A third model using Among the interesting factors now found to modulate
CD8 T cell function are the acquisition of inhibitory natu-the murine LCMV infection utilized CD62L expression
and the time course of virus clearance after infection. ral killer cell receptors, such as CD94 (NKG2A) (Moser
et al., 2001, 2002). Inhibitory receptors have now beenThis third model demonstrated results that were the
opposite of the first model, as naive cells (CD62L) upon reported to modulate the functions of T cells in HIV and
EBV infections in humans and polyomavirus infectionsantigen exposure matured into effectors (CD62L), then
effector memory (CD62), and finally central memory in mice (Moser et al., 2001, 2002; Vely et al., 2001; De
Maria et al., 1997). Studies with persistent LCMV infec-(CD62L) (Wherry et al., 2003b).
Both human and mouse studies have shown some tions in mice, initiated as a consequence of high dose
infection with a widely disseminating strain (clone 13),consistency in the functional phenotypes of memory
cells, although there is still concern whether surface have illustrated how high viral loads can modulate T cell
frequencies and functions in complicated fashions (Za-phenotype correlates with functional phenotypes (Cata-
lina et al., 2002; Hislop et al., 2002). Central memory jac et al., 1998; Moskophidis et al., 1993). In the LCMV
system, some (e.g., NP396) specific T cells, which are(CCR7, CD62L [first and third models]) or early differ-
entiated (CD45, CD27, CD28 [second model]) pheno- probably most highly stimulated by antigen, are com-
pletely eliminated from the host. However, T cells withtypes appear to be more resistant to apoptosis and
cycle more rapidly, and, upon antigen exposure, are other specificities (e.g., GP33) undergo various states
of anergy in which there is a loss in cytolytic ability, IL-2,better at producing IL-2 and proliferating when com-
pared to the effector (CCR7, CD62L [first and third TNF, and then IFN production, in that order (Fuller and
Zajac, 2003; Wherry et al., 2003a). In LCMV persistentlymodels]) or late fully differentiated (CD45, CD27,
CD28 [second model]) phenotype memory T cells (Sal- infected hosts, the CD8 T cells seemed to be lost or
anergized more in lymphoid organs than in the peripherylusto et al., 1999; Champagne et al., 2001; Wherry et
al., 2003b). The interchangeability of these populations (Wherry et al., 2003a). This may reflect recent evidence
showing that LCMV-specific CD8 T cells during theremains unclear. As indicated in the third model, adop-
tive transfer studies in the mice have shown that effector acute infection are more resistant to apoptosis in periph-
eral than in lymphoid tissues (Wang et al., 2003). Thus,memory T cells can convert back into central memory
T cells, suggesting a reversible differentiation scheme tissue-dependent factors may influence the fate of
T cells.(Wherry et al., 2003b). On the other hand, a human T cell
receptor (TCR) repertoire study using CD45RA and This variation in phenotypes of memory T cell popula-
tions following different virus infections and betweenCD62L to define effector and memory populations found
that 90% of the clonotypes were not in common be- different epitopes of the same virus would favor the
concept that memory subsets are defined by their initialtween the effector and central memory CD8 T cell popu-
lations (Baron et al., 2003). This surprising result would and ongoing antigenic experience and cytokine environ-
ment. Similarly, there may be significant flexibility insuggest that a differentiation pathway between those
subsets was less likely or else that there was a very converting from one phenotype to another, depending
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on their local antigen or cytokine environment (Appay tant Ag might be selectively expanded as new major
clones. This flexibility of repertoire selection would beet al., 2002; Wherry et al., 2003b).
an advantage in both antiviral and antitumor responses
where antigenic variants can be quite common.Plasticity in Recognition
Despite heterogeneity in TCR usage, many epitope-Diversity of Antigen-Specific
specific responses have in the CDR3 region distinctMemory TCR Repertoires
amino acid motifs that are maintained between clono-Antigen-specific TCR repertoires are highly diverse. The
types and between different individuals. For example,adaptive immune response needs to recognize a large
in the human HLA-A2-restricted influenza A M1-58 V17number of foreign antigens and has evolved to generate
response, the amino acid motif IRSS is common (Nau-a diverse  TCR response by imprecise recombination
mov et al., 2003), and in the H2-Kd-restricted HLA-CW3of the variable, diversity, and junctional regions of the
V10 response in DBA/2 mice, SxG in the first three and  chains, coupled with pairing of one  and one
positions of the CDR3 region was a common motif (Mar-to two  chains per T cell. The development of MHC-
yanski et al., 1999). Other CDR3 binding motifs havetetramers has enhanced the study of viral antigen-spe-
been identified, including the murine H2-Db-restrictedcific T cell populations by allowing for the purification
NP396-specific V8.1 response (GxxN) in LCMV infec-of epitope-specific T cell populations. Using this tech-
tion (Wang et al., 2003) and the HLA-B14-restricted HIVnique, Perlman and colleagues examined the V13 TCR
Env EL9 response (GQG) (Cohen et al., 2002). Conserva-repertoire to a mouse hepatitis virus S510 epitope, se-
tion of CDR3 amino acid motifs suggests that they arequenced 35 to 85 TCR per mouse in nine mice, and
required for the TCR to bind to the MHC-ligand structure.estimated a frequency of 300–500 unique clonotypes
These similarities in V usage and amino acid motifsspecific for that epitope (Pewe et al., 1999). Stern and
can be thought of as the public specificities of epitope-colleagues demonstrated diversity in human memory
specific T cell responses that are similar between indi-CD4 T cell responses to influenza A using MHC class II
viduals.HLA-DR1-restricted tetramers to an HA epitope with 35
Private Specificity and Diversity between Individuals.different clonotypes out of 110 sequences (Camereon
Despite the public specificities in T cell responses, thereet al., 2002). Naumov et al. have shown in human studies
can be tremendous diversity in the TCR repertoire be-that the CD8 memory response to the HLA-A2-restricted
tween individuals. The TCR usage per epitope differsinfluenza A epitope M1-58-specific consisted of 141
between individual hosts, even though there might beunique clonotypes out of 500 V17 sequences (Naumov
general similarities in preferred TCR V usage or specificet al., 2003).
CDR3 amino acid motifs (Maryanski et al., 1999; Lin andBoth the influenza A M1-58-specific response and the
Welsh, 1998; Blattman et al., 2000; Camereon et al.,MHV S510-specific response included a small number
2002). Thus, the TCRs on the antigen-specific T cellof high-frequency clonotypes and a large number of
clones are unique to the individual, and these uniquelow-frequency clonotypes, which could be described by
regions have been referred to as the “private specificity”a power law-like distribution (Naumov et al., 2003; Pewe
for that epitope-specific response. This variation is
et al., 1999). This means that a small number of clones
probably a consequence of the random stochastic pro-
were present at high frequencies and ever-increasing
cess of TCR rearrangement in the thymus, which results
numbers of clones were present at lower and lower
in variations in the naive peripheral TCR repertoire, and
frequencies. Furthermore, when the structure of the M1- of the random stochastic process whereby a T cell en-
specific repertoire was analyzed by focusing on many counters an APC presenting its cognate ligand (Bousso
different subsets of the repertoire, such as clonotypes et al., 1998). T cell clones that are stimulated early may
using J2.7 or those whose CDR3 region encodes the dominate the response by interfering with the stimula-
amino acid sequence IRSS, the clonotype frequencies tion of other T cells (Yewdell and Bennink, 1999).
still maintained a power law-like distribution. This indi- Crossreactive Memory T Cells
cates a self similarity to the repertoire in which smaller Each of the T cells in this diverse pool of memory cells
subsections of the repertoire form a distribution similar is degenerate in the number of antigens it can recognize.
to that of the larger whole repertoire. The power law- It has been calculated, on the basis of positional analysis
like distribution and the self similarity, which described of various amino acid substitutions at different residues
this influenza A M1-58-specific response, suggested of a peptide, that a given TCR has the potential to recog-
that this repertoire was organized in the form of a fractal nize a million different peptide-MHC combinations (Ma-
system. Fractal systems occur throughout nature, in son, 1998). Reports of CD8 T cells recognizing epitopes
such common forms as snowflakes, trees, and blood encoded by apparently unrelated viruses are increasing.
vessels, where there is a self similarity of structure. We For example, crossreactive T cells have been reported
do not understand the mechanisms which drive the between influenza and hepatitis C viruses, human papil-
memory T cell repertoire to develop as a fractal system, lomavirus and human coronavirus, LCMV and Pichinde
but it is notable as it is also seen in B cell systems. This virus (PV), LCMV and vaccinia virus (VV), influenza and
type of organization may be another reflection of the rotavirus, and influenza and EBV (Wedemeyer et al.,
flexibility of the adaptive T cell immune response. The 2001; Nilges et al., 2003; Brehm et al., 2002; Shimojo et
high number of low-frequency clones means there is a al., 1989; Welsh et al., 2004; Selin et al., 1994). Cross-
great breadth to an epitope-specific memory response. reactive CD8 T cell responses are also observed within
Thus, if antigenic variants were to elicit the recall re- different strains of influenza virus and Dengue virus
sponse, then some of the many diverse low-frequency (Haanen et al., 1999; Spaulding et al., 1999).
Models for Crossreactivity. There are several mecha-clones expressing TCRs capable of recognizing the mu-
Immunity
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Figure 1. Plasticity of T Cell Repertoire during Viral Infections
The colored dots represent T cell populations that have different specificities. The intracellular IFN staining for epitope-specific responses
during particular viral infections are also depicted. A naive immune system is challenged with either of two heterologous viruses, LCMV or
PV, and generates a T cell response to the immunodominant epitopes. These acute responses then decline but maintain the same hierarchy
of immunodominant responses in the memory state. If an immune system that has been conditioned with one virus is exposed to the other
heterologous virus, T cell populations that are crossreactive with the two viruses (red outlined) will expand preferentially, dominate the
response, and go onto memory.
nisms by which a single T cell can interact with multiple Consequences of Plasticity in Memory
T Cell Recognitionantigens. Structural studies examining T cell crossreac-
tivity against a peptide-modified syngeneic target and Plasticity of Immunodominance Hierarchies. The mobili-
zation of crossreactive memory cells into a primaryan allogeneic target have shown that different regions
of the same TCR can bind to two different targets (Daniel immune response can alter the immunodominance of
subsequent T cell responses. In genetically identicalet al., 1998; Speir et al., 1998). This type of crossreactiv-
ity would be difficult to predict. However, a crossreac- animals with a naive immune system, the hierarchy of
T cells specific to immunodominant epitopes is consis-tion involving the same determinants on the TCR would
be easier to predict and identify by searching databases tent and predictable (Brehm et al., 2002). However, stud-
ies in humans have shown that there is variability in thefor peptide sequences with similar amino acids accessi-
ble to the TCR; this “molecular mimicry” method was hierarchies of T cells responding to different HLA-A2-
restricted HIV epitopes in individual patients (Betts etused to identify some of the crossreactive epitopes iden-
tified above (Mason, 1998; Wedemeyer et al., 2001). A al., 2000). This disparity in epitope hierarchies could be
caused either by genetics or by the environment, wherethird mechanism for T cell crossreactivity occurs when
a T cell, due to incomplete allelic exclusion of the TCR humans have a lifetime history of earlier infections that
may have altered the T cell repertoire and influence chain, expresses two different TCRs (Alam and Gas-
coigne, 1998). the immunodominance hierarchy. In fact, studies in the
mouse have shown that T cell immunodominance canCrossreactive T cells may have widely different affini-
ties to two different targets, but certain aspects of a be greatly affected by previous antigenic exposures that
might elicit crossreactive responses. Brehm et al.viral infection may augment the significance of a low-
affinity crossreaction. Studies on T cell recognition using showed that LCMV and PV encoded crossreactive epi-
topes, with six of eight amino acids in common (Figureamino acid substitutions in target peptide epitopes have
indicated that highly activated T cells during an acute 1) (Brehm et al., 2002). Responses to these epitopes
were subdominant in each infection, accounting for lessresponse in LCMV infection can lyse a broader range
of targets than can less activated T cells (Bachmann than 3% and 1% of the acute and memory CD8 re-
sponses, respectively, for each infection. However, ifet al., 1997). This suggests that lower-affinity altered
peptide ligands might more easily activate effectors or LCMV-immune mice were infected with PV, or if PV-
immune mice were infected with LCMV, the T cell re-effector memory cells in comparison to resting memory
CD8 T cells. The virus-induced cytokine environment sponses to these epitopes became dominant, reaching
levels as high as 20% of the CD8 T cells. In contrast,may also enhance crossreactive effector responses; for
instance, since cytokines such as IL-12 are known to T cell responses to the normally dominant epitopes were
much lower. Thus, infections with heterologous virusessynergize with antigen to enhance IFN production by
T cells it is easy to envision IL-12 enhancing IFN pro- can alter immunodominance when crossreactive re-
sponses are present. This phenomenon is reminiscentduction in low-affinity TCR interactions (Gately et al.,
1998). of the concept of clonal imprinting or original antigenic
Review
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T cells with one LCMV epitope specificity but other times
elicited the expansion of T cells with a different specific-
ity. This could be explained by the stochastic nature
of clonal dominance and by the private specificities in
antigen-specific TCR repertoires in each immune host.
This would predict that the proportion of epitope-spe-
cific memory T cells crossreactive with another antigen
would differ from host to host. This is indeed what we
have observed in LCMV-immune hosts challenged with
VV (Kim et al., 2002; S.K. Kim and R.M.W., unpublished
data) (Figure 2).
Prior immunity to LCMV also had a dramatic impact
on immunopathology upon VV challenge. In the systemic
(i.p.) model, the mice developed severe mononuclear
infiltration and acute necrosis of the visceral fat pads
(Selin et al., 1998). This type of pathology is known as
panniculitis, and it can occur in humans with lupus ery-
thematosis and Weber-Christian syndrome (Welsh and
Selin, 2002). The most common form of panniculitis in
Figure 2. Private Specificity Drives Selective Expansion of Cross-
humans is erythema nodosum, a pathology associatedreactive Clones
with viral and intracellular bacterial infections and some-The colored dots represent unique T cell clones that all recognize
times observed after vaccination of humans with VVthe same antigen. In a naive host, each individual host develops a
or hepatitis B antigen (Di Giusto and Bernhard, 1986;unique repertoire of antigen-specific cells to the same immunodomi-
nant epitope during LCMV infection. Depending on the private speci- Bolognia and Braverman, 1992). The respiratory infec-
ficity of the TCR repertoire in each host, this repertoire may contain tion with VV resulted in dramatic differences in pathol-
memory T cells crossreactive with allo-antigens (mouse A) or with ogy, associated with accumulation of LCMV-specific
autoantigens (mouse B). If there are LCMV-specific memory T cells CD8 T cells in a greatly enhanced bronchus-associated
crossreactive with a heterologous virus, such as VV, as in mouse A
lymphocyte tissue (BALT) surrounding the airways and(yellow dots), these would preferentially expand upon infection with
with the induction of bronchiolitis obliterans (Chen etVV. A portion of the LCMV-specific memory T cells that are not
al., 2001), which can be observed in humans sporadicallycrossreactive with the second virus VV (mouse B) are lost due to
bystander attrition as the host accommodates the new memory during viral and intracellular bacterial infections and dur-
T cells. ing lung transplant rejection (Schlesinger et al., 1998).
Human panniculitis and bronchiolitis obliterans are dis-
eases of unknown etiology and are thought to be medi-sin that was proposed initially to explain the anamnestic
ated by cellular immune responses.antibody response to crossreactive B cell epitopes of
Because of the tenuous balance between T cell immu-
related influenza virus strains (Fazekas de St. Groth and
nodominance, protective immunity, and immunopathol-
Webster, 1966).
ogy, heterologous immunity is not always beneficial.
Heterologous Immunity. The mobilization of cross-
Although immunity to LCMV protected against respira-
reactive memory cells into a primary immune response tory VV infection, it inhibited the clearance of RSV (Chen
can alter not only immunodominance profiles but also et al., 2001; Ostler et al., 2003). Similarly, a history of
disease outcome by influencing both protective immu- influenza A infection protected against VV but inhibited
nity and immunopathology. Protective heterologous im- clearance of MCMV and LCMV (Chen et al., 2003). During
munity has been shown with a number of viruses (Selin MCMV infection, prior immunity to influenza A also dra-
et al., 1998, 2000; Welsh and Selin, 2002). For instance, matically altered early cytokine profiles, enhancing pro-
LCMV-immune mice challenged with VV (LCMV  VV) inflammatory cytokines, such as IL-6, IL-12, and IL-1
demonstrated partial protective immunity at 4 days (Figure 3). Instead of the usual mild mononuclear infil-
postinfection, with altered immunopathology in both trate observed in acute MCMV infection of naive mice,
systemic (i.p.) and respiratory (i.n.) infection models influenza-immune mice infected with MCMV developed
(Selin et al., 1998; Chen et al., 2001). Protective immunity a severe consolidating mononuclear pneumonia with
was transferred by LCMV-immune CD8 and CD4 T cell evidence of bronchiolization (Figure 3). During bronchio-
populations and was dependent on IFN. Notably, at 3 lization, alveolar epithelium is replaced by bronchiolar-
days after VV infection, 15%–30% of lung memory CD8 like cells, and this is thought to be an indicator of lung
T cells specific to each of six LCMV epitopes produced repair (Nettesheim and Szakal, 1972). Patterns of heter-
IFN in vivo. It is not clear whether this early IFN pro- ologous immunity can therefore be complicated and
duction was caused by crossreactivity or by a nonselec- difficult to predict, although they are quite reproducible
tive cytokine-dependent activation, but the IFN con- in experimental models.
tributed to the clearance of VV. Later in infection there We suggest that heterologous immunity may underlie
was a selective expansion LCMV-specific T cells with variabilities in pathology observed in some human viral
some but not other epitope specificities, consistent with infections. It is noteworthy that many viruses, including
a crossreactive antigen-driven expansion (Welsh et EBV, VZV, and measles, cause more severe pathology
al., 2004). in young adults than in children (Weinstein and Meade,
Our studies with VV infection of LCMV immune mice 1956; Rickinson and Kieff, 1996). The much larger reper-
toire of memory T cells from earlier infections presentshowed that VV sometimes elicited the expansion of
Immunity
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Figure 3. Previous Immunity to Influenza A Alters Early Cytokine Profiles and Immunopathology in the Lung on MCMV Infection
During MCMV infection of influenza A-immune mice there is a dramatic alteration of early cytokine profiles in the lung, as measured by Rnase
protection assay, with enhanced proinflammatory cytokines IL-6, IL-12, and IL-1, as well as IFN. Influenza A-immune mice have essentially
normal lung architecture, with only mild residual scaring (ii). MCMV infection of naive mice results in mild mononuclear infiltrates (i), but MCMV
infection in influenza A-immune mice results in a severe mononuclear pneumonia (iii) with evidence of bronchiolization (iv).
in the young adult might lead to recruitment of cross- memory phenotype, but, as a consequence of cross-
reactivity, viral infections leave mice with much higherreactive T cells and altered disease pathology.
Heterologous Immunity and Transplantation. Cross- frequencies of allo-specific memory T cells. For exam-
ple, about 1% of the CD8 T cells in LCMV-immunereactive T cell responses may play a role in organ trans-
plant rejection. Many virus infections in mice and man C57BL/6 mice (H2b) are memory cells specific to H2d
alloantigens (Brehm et al., 2003). Crossreactivity withinduce epitope-specific T cell responses to viruses that
crossreact with allogeneic MHC molecules (Nahill and alloantigens is extremely diverse, in that some of the
T cells specific to each of four tested LCMV-encodedWelsh, 1993; Brehm et al., 2003; Burrows et al., 1999),
and viral infections have often been noted to precede epitopes reacted against allogeneic targets expressing
H2d. Considerable effort has gone into developing toleri-allograft rejection in humans (Gaston and Waer, 1985).
Naive mice have very few allospecific T cells of the zation protocols to enable hosts to accept and maintain
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allogeneic tissue engraftment. However, mice with a et al., 1998). Mice infected with influenza virus before
history of viral infections are more difficult to tolerize vaccination with VV-RSV G protein developed a Th1-
to accept grafts (Welsh et al., 2000), and acute viral type response on RSV challenge instead of the expected
infections can break tolerance and stimulate the rejec- Th2 response and cleared RSV without developing se-
tions of allografts in tolerized mice (Brehm et al., 2003; vere eosinophilia (Walzl et al., 2000). Thus, memory
Adams et al., 2003). T cells specific to heterologous agents may affect the
Heterologous Immunity and Autoimmunity. Reactiva- Th1 or Th2 bias on subsequent exposure to allergens
tion of crossreactive memory T cells may play a role or new infections.
in mediating autoimmune diseases, such as multiple
sclerosis, diabetes mellitus, Crohn’s disease, or rheu- Plasticity in Accommodation
matoid arthritis. Virus-induced autoimmunity may be a Epidemiological data have shown that resistance to rein-
consequence of many factors, including disregulation fection is lost after some types of infections or vaccina-
of regulatory T cells or providing helper factors for self- tions but not others. Attenuated viral vaccines tend to
reactive T cells. However, there may be conditions be stronger and longer-lasting immunogens than inacti-
where there is a direct crossreactivity between viral and vated viral vaccines, and this has been linked to their
self antigens, and such T cells might get activated again ability to replicate in antigen-presenting cells, to stimu-
by another viral infection. An HSV-specific CD8 T cell late CD8 T cell immunity, and perhaps to maintain a
response in mice is directed against a viral epitope that low-grade persistence after the immunization. Protec-
is sufficiently similar to a corneal self antigen to induce tive immunity against small pox as a consequence of
autoimmune herpes stromal keratitis (Zhao et al., 1998). vaccinia virus immunization wanes after a few years, but
Some EBV-specific CD8 T cell clones, which recognize VV does not induce any type of detectable persistence
crossreactive self peptides, have been found in joints (Hammarlund et al., 2003). These observations had led
of humans afflicted with rheumatoid arthritis (Edinger et to the speculation that persisting antigen is required to
al., 1999; Misko et al., 1999). Mice expressing an LCMV maintain immunological memory, but numerous experi-
NP transgene in the brain develop transient encephalitis ments in mouse models have indicated that this certainly
after infection with LCMV but not with heterologous vi- is not the case with CD8 T cells. Memory CD8 T cell
ruses PV or VV (Evans et al., 1996). However, after LCMV frequencies remain very stable after resolution of infec-
has broken tolerance and elicited a memory CD8 T cell tions with LCMV, PV, VV, and influenza (Selin et al.,
response that is specific to the self “NP” antigen ex- 1996; Mullbacher, 1994; Lau et al., 1994), and adoptively
pressed in the brain, subsequent infections with these transferred virus-specific memory T cells rapidly reach
heterologous viruses are now able to reactivate these a steady state in a recipient host (Kim et al., 2002; Lau
memory T cells and reelicit the disease. This may be et al., 1994). This CD8 T cell stability is maintained by
a mechanism for autoimmune diseases that undergo an IL-15-dependent continuous low-grade division of all
exacerbations and remissions. of the memory CD8 T cells (Zhang et al., 1998).
Crossreactive CD4 T cell responses between patho- These seemingly disparate observations are ex-
gens and self antigens have also been associated with
plained by the fact that the memory CD8 T cell stability
autoimmune disease. For instance, infection of SJL/J
seen in the murine studies occurs in hosts that do not
mice with the neurotropic picornavirus Theiler’s murine
encounter other infections or strong antigenic chal-
encephalomyelitis virus (TMEV) leads to a late onset
lenges. The stability of memory CD8 T cell frequenciesCD4 T cell-mediated demyelinating disease similar to
is greatly disrupted by other infections, which lead to amultiple sclerosis (Olson et al., 2001; Theil et al., 2001).
loss in memory to previously encountered antigensWhen a TMEV variant was engineered to encode a pep-
(Selin et al., 1996, 1999; Smith et al., 2002). Thus, thetide containing the encephalitogenic myelin proteolipid
apparent need for antigen persistence to maintain long-protein (PLP139-151) epitope, mice infected with this
term memory in humans may have more to do withvirus developed a rapid onset paralytic demyelinating
restimulating memory populations reduced after otherdisease. Furthermore, mice infected with TMEV encod-
infections than with an absolute need of memory cells toing a variant peptide, which shared only 6 of 13 amino
receive an antigenic stimulus to survive. Several recentacids with PLP139-151, also displayed rapid-onset dis-
publications have stressed the long-term stability ofease and developed Th1-type CD4 T cells crossreactive
CD8 T cells specific to nonpersistent human viruseswith PLP139-151.
but there still is greater than a 10-fold loss with timeHeterologous Immunity and Immune Deviation. Reac-
(Hammarlund et al., 2003).tivation of memory T cells may be one of many factors
Part of the plasticity of the memory CD8 T cell re-contributing to immune deviation. If a memory pool is
sponse is its volatility in the wake of infections. Deletionsheavily populated with Th1 or with Th2 memory CD4
in memory T cells have been observed in the very earlyT cells, the stimulation of them by a crossreactive anti-
stages of viral and bacterial infections and have beengen may alter the cytokine milieu of a new immune
associated with the phenomenon of virus-induced lym-response and influence the Th1/Th2 polarity. Individuals
phopenia (Peacock et al., 2003; McNally et al., 2001;who have been immunized with Bacillus Calmette-Gue-
Jiang et al., 2003a). Permanent losses of memory T cellsrin (BCG), a strong Th1 inducer, have a decreased fre-
specific to previously encountered viruses have alsoquency of atopy, which is Th2 dependent, as compared
been shown to occur in the long-term memory stateto those who did not receive this immunization (Shira-
after subsequent viral or bacterial infections (Selin etkawa et al., 1997). Also, mice immunized with BCG sup-
al., 1999; Smith et al., 2002). A pertinent question ispressed a Th2-type response and the associated eosin-
ophilia in the lung when exposed to an allergen (Erb whether these events are interrelated or distinct.
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Attrition of Memory Early in Acute Viral Infection fide antigen-specific memory T cells also compete
poorly with the homeostatically proliferating pseudo-Infections with many viruses, including measles, influ-
enza, West Nile, Ebola, varicella zoster, and LCMV, in- memory T cells not specific for the virus (Peacock et
al., 2003). When CSFE-labeled LCMV- or PV-immuneduce a dramatic lymphopenia early in infection (Peacock
et al., 2003). Mechanisms for this lymphopenia are likely splenocytes were transferred into environments ren-
dered lymphopenic by irradiation, genetic deficiencies,to be diverse, but in the LCMV system it is dependent
on, though not necessarily directly mediated by, type 1 or viral infections, the bona fide virus-specific T cells
competed poorly with other T cells in the donor popula-IFN and does not require IFN or Fas/FasL interactions
(McNally et al., 2001). The lymphopenia, which occurs tion, underwent fewer cell divisions, and were diluted
about 10-fold as other pseudomemory T cells expandedthroughout the body’s lymphoid and peripheral organs,
is particularly devastating to CD8 T cells of the memory to replete the host. Thus, there appear to be strong
obstacles inhibiting the recovery of bona fide memoryphenotype, i.e., those coexpressing CD44 or else re-
acting with tetramers to previously encountered viruses cells that have been depleted by virus-induced lympho-
penia.(McNally et al., 2001; Jiang et al., 2003a; Peacock et al.,
2003). This can be mimicked in mice with inoculations Attrition of Memory T Cells over Time Following
Subsequent Heterologous Infectionsof the double-stranded RNA analog poly I:C, and it does
not occur in mice lacking type 1 IFN receptors. Memory A separate observation possibly related to the above
mentioned lymphopenia is the finding that viral infec-CD8 T cell loss can be as high as 80% after inoculation
of mice with poly I:C. The memory T cell loss is by tions cause a permanent loss in memory to previously
encountered viruses. This was initially shown by limitingapoptosis, as the residual T cells react with annexin V
and stain with markers for caspase activation. dilution assays in mice infected with LCMV, PV, VV, and
MCMV in sequence (Selin et al., 1996), but it has sinceA question that arises is whether the virus-induced
lymphopenia actually aids in the vigorous induction of been established in other viral and bacterial infections
by more sensitive assay techniques (Selin et al., 1999;the virus-specific T cell response by making room for
the development and proliferation of more T cells. It Smith et al., 2002). The question is, what frequencies
can be maintained in the memory state and with LCMVhas long been known that T cell responses to diverse
antigens improve in hosts rendered slightly lymphopenic over 20% of the CD8 T cells and over 30% of the CD44hi
CD8 T cells can be shown to be LCMV specific longby irradiation or cytotoxic drug treatment (Oehen and
Brduscha-Riem, 1999). For, example, T cell responses after resolution of infection (Peacock et al., 2003). These
high frequencies mean that the capacity of a host toto HSV are more profound in hosts treated with low
doses of cyclophosphamide (Pfizenmaier et al., 1977). accommodate T cells specific to a wide variety of patho-
gens is limited, instead of being a proverbial bottomlessThe relationship between these events remains unclear,
but it has recently been shown that the virus-induced pit. Here, the immune system demonstrates plasticity
by deleting some memory T cells in order to accommo-lymphopenia is more dramatic in young than in old mice,
and young mice tend to generate a stronger T cell re- date others.
One can envision two models to account for the long-sponse to a virus than old mice (Jiang et al., 2003b).
Bona Fide Memory Cells versus Homeostatically Di- term reduction in memory CD8 T cells specific to previ-
ous pathogens after a host encounters a second patho-viding Cells with a Memory Phenotype. The recovery of
bona fide memory CD8 T cells from their lymphopenia- gen. A passive, or competition model, would predict that
there are a finite number of survival niches for memoryassociated loss would be dependent on their ability to
compete with the antigen-specific T cells responding to cells in the lymphoid organs, and the large numbers of
newly arising CD44hi CD8 T cells simply compete withthe ongoing infection and with T cells homeostatically
expanding to fill the lymphopenic environment. Interest- the previously residing cells for these niches. An active
model would predict that there is a mechanism thatingly, lymphopenic environments induce the homeo-
static proliferation of CD8 T cells, which expand in num- selectively kills off the preexisting memory cells. The
obvious candidate for such an active model would be theber until the environment is replete with cells that
phenotypically resemble bona fide memory cells (Freitas lymphopenia that occurs early during infection. Recent
kinetic studies on the survival of PV-specific T cells afterand Rocha, 2000). These naive CD44lo CD8 T cells,
which upregulate CD44 and proliferate in response to LCMV infection in mice have indicated that the memory
cells, once depleted, fail to recover and remain depletedsignals from IL-7 and IL-15, represent another example
of the plasticity in functional phenotypes of memory in long-term memory (Kim and Welsh, 2004). This argues
on behalf of the active model, though it certainly seemsT cell populations (Tan et al., 2002; Goldrath et al., 2002).
Not all of these cells proliferate comparably, and it is that under some conditions competition between the
old and new memory cells must be a factor.thought that those undergoing the greatest degree of
homeostatic division may be self reactive with host anti- Attrition during Persistent Virus Infections
The depleted populations of virus-specific memorygens. The net effect is that there are considerable num-
bers of these CD44hi CD8 “pseudomemory” cells that T cells stay at reduced frequencies after resolution of
infection but then remain stable thereafter, unless thehave not gone through the differentiation scheme of
bona fide memory cells. host receives another infection (Selin et al., 1996, 1999).
These dynamics change under conditions of persistentCD8 T cells responding to the new viral antigens prolif-
erate vigorously at a rate of about three divisions a infections. Persistent infections with mouse  herpes
virus or with LCMV-clone 13 can cause a dramatic attri-day and rapidly dilute out preexisting bona fide memory
T cells unless those T cells are crossreactive with the tion of preexisting memory (Liu et al., 2003; S.K. Kim
and R.M.W., submitted). Adoptive transfer studies ofnew virus (Selin et al., 1996; Brehm et al., 2002). Bona
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Figure 4. Accommodation of New Memory T Cells on Heterologous Virus Infection
The colored dots represent T cell populations that have different specificities. The intracellular IFN staining for epitope-specific responses
during particular viral infections are also depicted. The immunodominant hierarchy of antigen-specific responses is established during the
peak of the CD8 T cell response to virus and remains the same during the silencing phase into memory for both LCMV and PV infection. After
a heterologous virus infection, such as PV challenge of an LCMV-immune host, the LCMV-specific hierarchy is modified, the crossreactive-
epitope responses (NP205) are preserved and expanded in response to PV infection, and the noncrossreactive epitope responses are reduced
in number. In an LCMV-immune host, the PV-specific immunodominant hierarchy is different from that of a naive host, with the crossreactive
epitope response (NP205) being immunodominant.
CFSE-labeled PV-immune splenocytes into mice persis- permanently changed by subsequent infections with pu-
tatively unrelated viruses. Significantly, these continu-tently infected with LCMV as adults and mounting a
low-grade antiviral T cell response led to a substantial ously evolving memory T cell responses participate in
and influence disease outcome of each new infection,deletion of the PV-specific T cells, in comparison to
control or LCMV-immune recipients (S.K. Kim and whether it be harmful or beneficial to the host.
R.M.W., submitted). Thus, persistent infections may en-
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